Clinical Trials

Clinical trials are key to ensuring that we are providing physicians with state-of-the-art technology and science to treat patients. Avedro is currently recruiting for the following clinical trials:

ACOS-KXL-001

Overview
A multi-center, randomized, controlled evaluation of the safety and efficacy of the KXL® System with VibeX™ (riboflavin ophthalmic solution) for corneal collagen cross-linking in eyes with keratoconus or corneal ectasia after refractive surgery.
Study Phase
III
Learn More
ACOS-KXL-001 Study

KXL-001

Overview
A multi-center, randomized, placebo-controlled evaluation of the safety and efficacy of the KXL System with VibeX (riboflavin ophthalmic Solution) for corneal collagen cross-linking in eyes with keratoconus.
Study Phase
III
Learn More
KXL-001 Study

KXL-002

Overview
A multi-center, randomized, placebo-controlled evaluation of the safety and efficacy of the KXL System with VibeX (riboflavin ophthalmic solution) for corneal collagen cross-linking in eyes with keratoconus.
Study Phase
III
Learn More
KXL-002 Study

Avedro’s cross-linking systems and family of riboflavin products are not for sale in the US. MA-00314A

Share on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Share on RedditEmail this to someone